Cubist Systematic Strategies’s Amedisys AMED Stock Holding History

Cubist Systematic Strategies’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-19,400	Closed	-$1.81M	–	3539
2023 Q3	$1.81M	Sell	19,400 -2,500	-11%	-$231K	0.01%	1434
2023 Q2	$2M	Buy	+21,900	New	+$1.8M	0.01%	1483
2023 Q1	–	Sell	-2,400	Closed	-$200K	–	3864
2022 Q4	$200K	Buy	+2,400	New	+$216K	﹤0.01%	3580

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cubist Systematic Strategies's AMED Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,291 shares — an estimated $619K sold.

Cubist Systematic Strategies first reported a position in AMED in Q3 2014 and held it in 32 quarters. The position peaked at $12.7M in Q3 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Cubist Systematic Strategies reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Cubist Systematic Strategies sold 6,291 Amedisys shares in Q3 2025, an estimated $619K.
Cubist Systematic Strategies first reported a position in Amedisys in Q3 2014 and held it in 32 quarters.
Cubist Systematic Strategies's Amedisys position peaked at $12.7M in Q3 2021.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.